Published in Clin Exp Immunol on May 01, 1976
Anti-actin specificity of human smooth muscle antibodies in chronic active hepatitis. Clin Exp Immunol (1976) 2.24
Smooth muscle autoantibodies and autoantigens. Clin Exp Immunol (1979) 1.42
Oligoclonal immunoglobulins and smooth muscle antibodies in arthritic joints. Clin Exp Immunol (1980) 1.06
Autoantibodies to the mitotic spindle apparatus in Mycoplasma pneumoniae disease. Infect Immun (1988) 0.99
Mechanisms of smooth muscle antibody production: a clinical study in children with infections, haemolytic syndromes, and idiopathic thrombocytopenic purpura. J Clin Pathol (1979) 0.92
Antibodies to skeletal muscle actin and their reactivity with malignant melanoma of the choroid. Br J Ophthalmol (1980) 0.80
Anticentriolar autoantibodies in children with central nervous system manifestations of Mycoplasma pneumoniae infection. J Neurol Neurosurg Psychiatry (1994) 0.80
Adsorption of Mycoplasma pneumoniae to neuraminic acid receptors of various cells and possible role in virulence. J Bacteriol (1968) 5.81
Antibody to smooth muscle in patients with liver disease. Lancet (1965) 5.71
Smooth muscle antibody in malignant disease. Br Med J (1971) 4.54
Relationships Between Mycoplasma pneumoniae and Human Respiratory Epithelium. Infect Immun (1971) 4.14
Autoantibodies and the hepatitis-associated antigen in acute infective hepatitis. Br Med J (1970) 4.08
Reaction of human smooth muscle antibody with liver cells. Nat New Biol (1971) 4.06
Autoimmune hepatitis. Immunofluorescence reactions with cytoplasm of smooth muscle and renal glomerular cells. Lancet (1966) 3.45
The interaction of mycoplasmas with mammalian cells. I. HeLa cells, neutrophils, and eosinophils. J Exp Med (1966) 3.38
Human smooth muscle autoantibody. Its identification as antiactin antibody and a study of its binding to "nonmuscular" cells. Am J Pathol (1973) 3.36
Antibodies to brain and other tissues in cases of Mycoplasma pneumoniae infection. Clin Exp Immunol (1971) 2.76
Smooth muscle autoantibodies in infectious mononucleosis. Br Med J (1973) 2.44
Anti-actin specificity of human smooth muscle antibodies in chronic active hepatitis. Clin Exp Immunol (1976) 2.24
Immunofluorescent tracing of smooth muscle contractile protein antigens in tissues other than smooth muscle. Clin Exp Immunol (1974) 1.93
Immunological studies in an epidemic of infective, short-incubation hepatitis. Lancet (1972) 1.62
Reaction of human smooth muscle antibodies with human blood lymphocytes and lymphoid cell lines. Nature (1974) 1.54
Autoantibodies in patients with carcinoma of the breast. Correlation with prognosis. Clin Exp Immunol (1975) 1.44
Reaction of human smooth muscle antibody with thyroid cells. Clin Exp Immunol (1974) 1.24
Reaction of human smooth muscle antibody with thymus medullary cells. Nat New Biol (1973) 1.22
Smooth muscle antibody in patients with warts. Clin Exp Immunol (1975) 1.14
Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet (1986) 7.09
Ultrastructural features of Mycoplasma pneumoniae. J Bacteriol (1970) 3.84
Outbreak of giardiasis: effect of a new antiflagellate drug, tinidazole. Br Med J (1972) 3.23
HIV counseling and testing of pregnant women in sub-Saharan Africa: experiences from a study on prevention of mother-to-child HIV-1 transmission in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr (2001) 2.81
Antibodies to brain and other tissues in cases of Mycoplasma pneumoniae infection. Clin Exp Immunol (1971) 2.76
The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J Virol (2000) 2.55
Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys. Nature (1991) 2.28
Anti-actin specificity of human smooth muscle antibodies in chronic active hepatitis. Clin Exp Immunol (1976) 2.24
Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure. Karolinska Institute Primary HIV Infection Study Group. AIDS (2000) 2.08
Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection. J Virol (1987) 1.99
New human and simian HIV-related retroviruses possess functional transactivator (tat) gene. Nature (1987) 1.93
HTLV-III expression in infected lymph nodes and relevance to pathogenesis of lymphadenopathy. Am J Pathol (1986) 1.88
Mycoplasma pneumoniae is a polyclonal B-cell activator. Nature (1976) 1.83
Comparison of in-house and commercial sample preparation and PCR amplification systems for detection of human immunodeficiency virus type 1 DNA in blood samples from Tanzanian adults. J Clin Microbiol (1997) 1.76
Monitoring of HIV-1 infection prevalence and trends in the general population using pregnant women as a sentinel population: 9 years experience from the Kagera region of Tanzania. J Acquir Immune Defic Syndr (2000) 1.70
A new human retrovirus isolate of West African origin (SBL-6669) and its relationship to HTLV-IV, LAV-II, and HTLV-IIIB. AIDS Res Hum Retroviruses (1987) 1.67
Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages. J Immunol (1987) 1.61
Respiratory syncytial virus. An outbreak of acute respiratory illnesses in a home for infants. Acta Paediatr Scand (1966) 1.60
Discrimination between antibodies to HIV and to related retroviruses using site-directed serology. Nature (1987) 1.59
Reaction of human smooth muscle antibodies with human blood lymphocytes and lymphoid cell lines. Nature (1974) 1.54
Blood donor sera with false-positive Western blot reactions to human immunodeficiency virus. Lancet (1986) 1.53
The mixed haemadsorption test as an aid to the diagnosis of thyroid autoimmune disease. Clin Exp Immunol (1968) 1.52
Molecular and biological characterization of a replication competent human immunodeficiency type 2 (HIV-2) proviral clone. Proc Natl Acad Sci U S A (1989) 1.48
Lymphocyte subset enumeration in HIV seronegative and HIV-1 seropositive adults in Dar es Salaam, Tanzania: determination of reference values in males and females and comparison of two flow cytometric methods. J Immunol Methods (2003) 1.45
Central nervous system complications of Mycoplasma pneumoniae infection. Scand J Infect Dis (1969) 1.41
Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa? AIDS (2005) 1.41
Evaluation of 14 commercial HIV-1/HIV-2 antibody assays using serum panels of different geographical origin and clinical stage including a unique seroconversion panel. J Virol Methods (1998) 1.39
T-lymphocyte subpopulations in relation to immunosuppression in measles and varicella. Infect Immun (1983) 1.37
Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection. Arch Intern Med (2000) 1.37
Protection against mucosal SIVsm challenge in macaques infected with a chimeric SIV that expresses HIV type 1 envelope. AIDS Res Hum Retroviruses (1996) 1.36
Immunohistopathology of lymph nodes in HTLV-III infected homosexuals with persistent adenopathy or AIDS. Cancer Res (1985) 1.36
Performance of a modified HIV-1 p24 antigen assay for early diagnosis of HIV-1 infection in infants and prediction of mother-to-infant transmission of HIV-1 in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.34
Field evaluation of alternative testing strategies for diagnosis and differentiation of HIV-1 and HIV-2 infections in an HIV-1 and HIV-2-prevalent area. AIDS (1997) 1.31
Oral candida albicans in HIV infection. Scand J Infect Dis (1987) 1.31
Immunological changes in primary HIV-1 infection. AIDS (1990) 1.30
Live attenuated simian immunodeficiency virus (SIV)mac in macaques can induce protection against mucosal infection with SIVsm. AIDS (1998) 1.27
Evaluation of the FACScount, TRAx CD4 and Dynabeads methods for CD4 lymphocyte determination. J Immunol Methods (1996) 1.27
Prevalence of HIV-1 infection in the Kagera region of Tanzania: a population-based study. AIDS (1990) 1.26
The use of iohexol clearance to determine GFR in patients with severe chronic renal failure--a comparison between different clearance techniques. Clin Nephrol (1995) 1.24
Reaction of human smooth muscle antibody with thyroid cells. Clin Exp Immunol (1974) 1.24
The effect of irradiation on T-cell suppression of ELISA-determined Ig production by human blood B-cells in vitro. Clin Exp Immunol (1979) 1.22
Reaction of human smooth muscle antibody with thymus medullary cells. Nat New Biol (1973) 1.22
Histopathology and immunohistology of HTLV-III/LAV related lymphadenopathy and AIDS. Acta Pathol Microbiol Immunol Scand A (1987) 1.21
A cystatin C-based formula without anthropometric variables estimates glomerular filtration rate better than creatinine clearance using the Cockcroft-Gault formula. Scand J Clin Lab Invest (2005) 1.20
Trends and interaction of HIV-1 and HIV-2 in Guinea-Bissau, west Africa: no protection of HIV-2 against HIV-1 infection. AIDS (1999) 1.19
Impaired specific cellular response to HTLV-III before other immune defects in patients with HTLV-III infection. N Engl J Med (1986) 1.18
Antibodies in bronchial secretions following natural infection with Mycoplasma pneumoniae. Acta Pathol Microbiol Scand B Microbiol Immunol (1971) 1.16
Vaccine protection against HIV-2 infection in cynomolgus monkeys. AIDS Res Hum Retroviruses (1991) 1.16
Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus. AIDS Res Hum Retroviruses (1997) 1.16
Experimental infection of cynomolgus monkeys (Macaca fascicularis) with HIV-2. J Acquir Immune Defic Syndr (1989) 1.16
The accuracy of an alternative confirmatory strategy for detection of antibodies to HIV-1: experience from a regional laboratory in Kagera, Tanzania. J Clin Virol (1999) 1.14
Activation of human lymphocyte subpopulations by Mycoplasma pneumoniae. Scand J Immunol (1977) 1.14
Circulating immune complexes in Mycoplasma pneumoniae infection. J Immunol (1974) 1.13
Immunogenicity and protective efficacy of a human immunodeficiency virus type 2 recombinant canarypox (ALVAC) vaccine candidate in cynomolgus monkeys. J Infect Dis (1996) 1.13
Site-directed ELISA with synthetic peptides representing the HIV transmembrane glycoprotein. J Med Virol (1987) 1.13
Optimal blood mononuclear cell isolation procedures for gamma interferon enzyme-linked immunospot testing of healthy Swedish and Tanzanian subjects. Clin Vaccine Immunol (2008) 1.13
A prospective study of vertical transmission of HIV-2 in Bissau, Guinea-Bissau. AIDS (1993) 1.11
Evaluation of commercial enzyme immunoassays for anti-HIV-1 using East African sera. AIDS (1988) 1.11
Acceptability of voluntary HIV testing with counselling in a rural village in Kagera, Tanzania. AIDS Care (1998) 1.11
Specific and non-specific B cell activation in measles and varicella. Clin Exp Immunol (1983) 1.11
Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection. Virology (1993) 1.11
Protection of human immunodeficiency virus type 2-exposed seronegative macaques from mucosal simian immunodeficiency virus transmission. J Virol (1997) 1.11
Enhancing adherence to antiretroviral therapy at the HIV clinic in resource constrained countries; the Tanzanian experience. Trop Med Int Health (2009) 1.10
Prevalence of HIV infection among hospital patients in north west Tanzania. AIDS Care (1999) 1.07
Alternative confirmatory strategies in HIV-1 antibody testing. J Acquir Immune Defic Syndr (1992) 1.06
Mycoplasma pneumoniae infection in hospitalized patients with acute respiratory illness. Acta Pathol Microbiol Scand (1968) 1.06
Affordable CD4+ T cell counts by flow cytometry. II. The use of fixed whole blood in resource-poor settings. J Immunol Methods (2001) 1.05
Cell-mediated immune response following Mycoplasma pneumoniae infection in man. I. Lymphocyte stimulation. Clin Exp Immunol (1974) 1.05
Effect of Mycoplasma pheumoniae infection on cell-mediated immunity. Infection (1976) 1.04
Malignant lymphomas in cynomolgus monkeys infected with simian immunodeficiency virus. Am J Pathol (1990) 1.04
Prevalence and incidence of syphilis and its association with HIV-1 infection in a population-based study in the Kagera region of Tanzania. Int J STD AIDS (1995) 1.04
Replicative capacity of HIV-2, like HIV-1, correlates with severity of immunodeficiency. AIDS (1990) 1.04
Prevalence of HIV-1 and HIV-2/HTLV-IV infections in Luanda and Cabinda, Angola. J Acquir Immune Defic Syndr (1988) 1.03
A monkey model for Epstein Barr virus-associated lymphomagenesis in human acquired immunodeficiency syndrome. J Exp Med (1992) 1.03
Prediction of relative glomerular filtration rate in adults: new improved equations based on Swedish Caucasians and standardized plasma-creatinine assays. Scand J Clin Lab Invest (2007) 1.01
Experimental infection of cynomolgus monkeys (Macaca fascicularis) with simian immunodeficiency virus (SIVsm). J Acquir Immune Defic Syndr (1989) 1.01
Use of erythromycin to prevent pertussis in newborns of mothers with pertussis. J Infect Dis (1987) 1.01
Distribution of antibodies within 19 S and 7 S immunoglobulins following infection with Mycoplasma pneumoniae. J Immunol (1968) 1.00
Improved detection of HIV-2 DNA in clinical samples using a nested primer-based polymerase chain reaction. J Acquir Immune Defic Syndr (1992) 1.00
Long-term protection against SIV-induced disease in macaques vaccinated with a live attenuated HIV-2 vaccine. Nat Med (1995) 1.00
PPD-induced viral antibody production in human blood lymphocytes. Clin Exp Immunol (1980) 1.00
Surface immunoglobulin light chain determinants on normal and PHA-stimulated human blood lymphocytes studied by immunofluorescence and electronmicroscopy. Exp Cell Res (1971) 1.00
Sexual behaviour among youths at high risk for HIV-1 infection in Dar es Salaam, Tanzania. Sex Transm Infect (2001) 0.99
Comparison of linear antigenic sites in the envelope proteins of human immunodeficiency virus (HIV) type 2 and type 1. AIDS Res Hum Retroviruses (1991) 0.99
Genetic analysis of a new subgroup of human and simian T-lymphotropic retroviruses: HTLV-IV, LAV-2, SBL-6669, and STLV-IIIAGM. AIDS Res Hum Retroviruses (1987) 0.99
Decline in the prevalence of HIV-1 infection in young women in the Kagera region of Tanzania. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 0.99
A capture enzyme immunoassay for detection of HIV-2/SIV antigen. J Acquir Immune Defic Syndr (1991) 0.98
HIV-2 infection in hospitalized patients in Bissau, Guinea-Bissau. AIDS (1991) 0.98
Antibodies against Mycoplasma pneumoniae in bronchial secretions. Acta Pathol Microbiol Scand (1969) 0.98
Detection of antibodies which mediate human immunodeficiency virus-specific cellular cytotoxicity (ADCC) in vitro. J Immunol Methods (1987) 0.98
Severe community-acquired pneumonia: factors influencing need of intensive care treatment and prognosis. Scand J Infect Dis (1985) 0.96
[Giardiasis--a problem of current interest in Sweden]. Nord Med (1971) 0.96